Clinical Trial Update: Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) [Phase 2, Phase 3]

View source ↗

Summary

This document reports an update on a pragmatic Phase 2/3 trial evaluating a more effective, concise, and less toxic regimen for multidrug-resistant and extensiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Tuberculosis Multidrug-resistant
• Tuberculosis Pulmonary

Snippet

Sponsor: Medecins Sans Frontieres, Netherlands | Conditions: Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis | Phase 2, Phase 3 | Status: COMPLETED